We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
116 hedge funds and large institutions have $252M invested in ANI Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
9% more funds holding
Funds holding: 106 → 116 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $263M → $252M (-$10.8M)
5% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 39
2.39% less ownership
Funds ownership: 59.05% → 56.66% (-2.4%)
70% less call options, than puts
Call options by funds: $245K | Put options by funds: $806K
Holders
116
Holders Change
+10
Holders Change %
+9.43%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
37
Reduced
39
Closed
8
Calls
$245K
Puts
$806K
Net Calls
-$561K
Net Calls Change
-$576K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$3.61M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$1.75M |
| 3 |
Renaissance Technologies
New York
|
-$1.63M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.35M |
| 5 |
Two Sigma Investments
New York
|
-$918K |
